4//SEC Filing
Elazzouzi Amy 4
Accession 0000950170-25-013825
CIK 0001501796other
Filed
Feb 3, 7:00 PM ET
Accepted
Feb 4, 5:51 PM ET
Size
7.2 KB
Accession
0000950170-25-013825
Insider Transaction Report
Form 4
Elazzouzi Amy
Senior Vice President, Finance
Transactions
- Award
Common Stock
2025-02-03+45,240→ 83,682 total - Award
Stock Option (Right to Buy)
2025-02-03+29,760→ 29,760 totalExercise: $7.68Exp: 2035-02-02→ Common Stock (29,760 underlying)
Footnotes (2)
- [F1]These shares were acquired pursuant to a restricted stock unit ("RSU") award under the Issuer's 2021 Stock Option and Incentive Plan. Each RSU represents the right to receive one share of the Issuer's Common Stock. These RSUs vest in four substantially equal annual installments beginning on February 15, 2026, subject to the Reporting Person's continued service as of each such vesting date.
- [F2]The shares underlying this option vest as follows: 25% of the shares vest on February 3, 2026 with the remainder vesting thereafter pro-rata in 36 monthly installments, subject to the Reporting Person's continued service as of each such vesting date.
Documents
Issuer
Aura Biosciences, Inc.
CIK 0001501796
Entity typeother
Related Parties
1- filerCIK 0002042910
Filing Metadata
- Form type
- 4
- Filed
- Feb 3, 7:00 PM ET
- Accepted
- Feb 4, 5:51 PM ET
- Size
- 7.2 KB